Jacquelyn O. Wolff
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 2
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Elizabeth Iannotti Buchbinder (1 shared paper)David F. McDermott (1 shared paper)Ryan Joseph Sullivan (1 shared paper)Anita Giobbie‐Hurder (1 shared paper)Donald P. Lawrence (1 shared paper)Scott J. Rodig (1 shared paper)Frank Stephen Hodi (1 shared paper)Patrick Alexander Ott (1 shared paper)
- Journals
- Blood (3 papers)Cancer Discovery (1 paper)Blood Advances (1 paper)Journal of Clinical Investigation (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Jacquelyn O. Wolff
12 papers receiving 622 citations
Peers
Comparison fields: 5 of 44
- Oncology 363
- Immunology 280
- Hematology 81
- Otorhinolaryngology 13
- Cancer Research 32
Countries citing papers authored by Jacquelyn O. Wolff
This map shows the geographic impact of Jacquelyn O. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacquelyn O. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacquelyn O. Wolff more than expected).
Fields of papers citing papers by Jacquelyn O. Wolff
This network shows the impact of papers produced by Jacquelyn O. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacquelyn O. Wolff. The network helps show where Jacquelyn O. Wolff may publish in the future.
Co-authors
The 13 scholars most cited alongside Jacquelyn O. Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 168 | |
| 2 | 2022 | 149 | |
| 3 | Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse | 2022 | 91 |
| 4 | 2023 | 80 | |
| 5 | 2022 | 44 | |
| 6 | 2023 | 43 | |
| 7 | 2022 | 25 | |
| 8 | 2021 | 14 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2025 | 2 |
About Jacquelyn O. Wolff
Jacquelyn O. Wolff is a scholar working on Immunology, Hematology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 12 papers that have together received 627 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Cancer Genomics and Diagnostics (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Immunotherapy and Immune Responses (2 papers) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Oncology (363 citations), Immunology (280 citations), Hematology (81 citations), Otorhinolaryngology (13 citations) and Cancer Research (32 citations). Jacquelyn O. Wolff has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Elizabeth Iannotti Buchbinder, David F. McDermott, Ryan Joseph Sullivan, Anita Giobbie‐Hurder, Donald P. Lawrence, Scott J. Rodig, Frank Stephen Hodi, Patrick Alexander Ott, Evisa Gjini and Rizwan Ul Haq. Their work appears in journals such as Blood, Cancer Discovery, Blood Advances, Journal of Clinical Investigation and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.